News & Updates
Showing Oncology articles
Showing
Show Multimedia Only

Adjuvant pembrolizumab continues to improve DFS in clear cell RCC
28 Sep 2022
byRoshini Claire Anthony
In patients with clear cell renal cell carcinoma (RCC), adjuvant pembrolizumab continues to improve disease-free survival (DFS) over placebo, according to extended follow-up of the phase III KEYNOTE-564 trial.
28 Sep 2022

First-line, reduced-dose eribulin mesylate disappoints in older adults with metastatic breast cancer
27 Sep 2022
Among older patients with metastatic breast cancer, first-line treatment with reduced-dose eribulin mesylate is reasonably safe but yields a low disease control rate, reports a recent phase II trial.
27 Sep 2022

Mammography uptake among Malay-Muslim women low, blamed on multilevel factors
26 Sep 2022
byJairia Dela Cruz
Breast cancer screening behaviour among Malay-Muslim women in Singapore appears to hinge on multilevel factors that involve not only personal relationships but also their religious beliefs and screening facilities’ availability and access.
26 Sep 2022





